The website you are trying to access is designed for UK healthcare professionals only.

The content is not designed for the general public.

If you are not a healthcare professional please visit for more further information.

If you are seeing this message on every page, you might want to review your cookie settings.

I am a UK healthcare professional and agree to use information accordingly

I am not a UK healthcare professional

Meda Pharmaceuticals Efudix®

Efudix® (5% Fluorouracil Cream)

Efudix® is used for the topical treatment of superficial pre-malignant and malignant skin lesions; keratoses including senile, actinic and arsenical forms; keratoacanthoma; Bowen’s disease; superficial basal-cell carcinoma. Deep, penetrating or nodular basal cell and squamous cell carcinomas do not usually respond to Efudix® therapy. It should be used only as a palliative therapy in such cases where no other form of treatment is possible.

Patient Information Leaflet

Material include:
*Efudix® Patient support leaflet